Skip to main content
Top
Published in: BMC Medicine 1/2020

01-12-2020 | Circumcision | Research article

Mapping male circumcision for HIV prevention efforts in sub-Saharan Africa

Authors: Michael A. Cork, Kate F. Wilson, Samantha Perkins, Michael L. Collison, Aniruddha Deshpande, Jeffrey W. Eaton, Lucas Earl, Emily Haeuser, Jessica E. Justman, Damaris K. Kinyoki, Benjamin K. Mayala, Jonathan F. Mosser, Christopher J. L. Murray, John N. Nkengasong, Peter Piot, Benn Sartorius, Lauren E. Schaeffer, Audrey L. Serfes, Amber Sligar, Krista M. Steuben, Frank C. Tanser, John D. VanderHeide, Mingyou Yang, Njeri Wabiri, Simon I. Hay, Laura Dwyer-Lindgren

Published in: BMC Medicine | Issue 1/2020

Login to get access

Abstract

Background

HIV remains the largest cause of disease burden among men and women of reproductive age in sub-Saharan Africa. Voluntary medical male circumcision (VMMC) reduces the risk of female-to-male transmission of HIV by 50–60%. The World Health Organization (WHO) and Joint United Nations Programme on HIV/AIDS (UNAIDS) identified 14 priority countries for VMMC campaigns and set a coverage goal of 80% for men ages 15–49. From 2008 to 2017, over 18 million VMMCs were reported in priority countries. Nonetheless, relatively little is known about local variation in male circumcision (MC) prevalence.

Methods

We analyzed geo-located MC prevalence data from 109 household surveys using a Bayesian geostatistical modeling framework to estimate adult MC prevalence and the number of circumcised and uncircumcised men aged 15–49 in 38 countries in sub-Saharan Africa at a 5 × 5-km resolution and among first administrative level (typically provinces or states) and second administrative level (typically districts or counties) units.

Results

We found striking within-country and between-country variation in MC prevalence; most (12 of 14) priority countries had more than a twofold difference between their first administrative level units with the highest and lowest estimated prevalence in 2017. Although estimated national MC prevalence increased in all priority countries with the onset of VMMC campaigns, seven priority countries contained both subnational areas where estimated MC prevalence increased and areas where estimated MC prevalence decreased after the initiation of VMMC campaigns. In 2017, only three priority countries (Ethiopia, Kenya, and Tanzania) were likely to have reached the MC coverage target of 80% at the national level, and no priority country was likely to have reached this goal in all subnational areas.

Conclusions

Despite MC prevalence increases in all priority countries since the onset of VMMC campaigns in 2008, MC prevalence remains below the 80% coverage target in most subnational areas and is highly variable. These mapped results provide an actionable tool for understanding local needs and informing VMMC interventions for maximum impact in the continued effort towards ending the HIV epidemic in sub-Saharan Africa.
Appendix
Available only for authorised users
Literature
1.
go back to reference James SL, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.CrossRef James SL, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.CrossRef
3.
go back to reference Gray RH, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–66.PubMedCrossRef Gray RH, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–66.PubMedCrossRef
4.
go back to reference Bailey RC, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–56.PubMedCrossRef Bailey RC, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–56.PubMedCrossRef
5.
go back to reference Auvert B, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.PubMedPubMedCentralCrossRef Auvert B, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.PubMedPubMedCentralCrossRef
6.
go back to reference Gray R, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS Lond Engl. 2012;26:609–15.CrossRef Gray R, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS Lond Engl. 2012;26:609–15.CrossRef
7.
go back to reference Auvert B, et al. Association of the ANRS-12126 male circumcision project with HIV levels among men in a south African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013;10:e1001509.PubMedPubMedCentralCrossRef Auvert B, et al. Association of the ANRS-12126 male circumcision project with HIV levels among men in a south African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013;10:e1001509.PubMedPubMedCentralCrossRef
8.
go back to reference Wamai RG, Morris BJ, Bailey RC, Klausner JD, Boedicker MN. Male circumcision for protection against HIV infection in sub-Saharan Africa: the evidence in favour justifies the implementation now in progress. Glob Public Health. 2015;10:639–66.PubMedPubMedCentralCrossRef Wamai RG, Morris BJ, Bailey RC, Klausner JD, Boedicker MN. Male circumcision for protection against HIV infection in sub-Saharan Africa: the evidence in favour justifies the implementation now in progress. Glob Public Health. 2015;10:639–66.PubMedPubMedCentralCrossRef
9.
10.
11.
go back to reference Wamai RG, et al. Criticisms of African trials fail to withstand scrutiny: male circumcision does prevent HIV infection. J Law Med. 2012;20:93–123.PubMed Wamai RG, et al. Criticisms of African trials fail to withstand scrutiny: male circumcision does prevent HIV infection. J Law Med. 2012;20:93–123.PubMed
12.
go back to reference Lei JH, et al. Circumcision status and risk of HIV acquisition during heterosexual intercourse for both males and females: a meta-analysis. PLoS One. 2015;10:e0125436.PubMedPubMedCentralCrossRef Lei JH, et al. Circumcision status and risk of HIV acquisition during heterosexual intercourse for both males and females: a meta-analysis. PLoS One. 2015;10:e0125436.PubMedPubMedCentralCrossRef
13.
go back to reference Davis SM, et al. Progress in voluntary medical male circumcision for HIV prevention supported by the US President’s Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data. BMJ Open. 2018;8(8):e021835. Davis SM, et al. Progress in voluntary medical male circumcision for HIV prevention supported by the US President’s Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data. BMJ Open. 2018;8(8):e021835.
14.
go back to reference Reed JB, et al. Voluntary medical male circumcision: an HIV prevention priority for PEPFAR. J Acquir Immune Defic Syndr. 2012;1999(60 Suppl 3):S88–95.CrossRef Reed JB, et al. Voluntary medical male circumcision: an HIV prevention priority for PEPFAR. J Acquir Immune Defic Syndr. 2012;1999(60 Suppl 3):S88–95.CrossRef
15.
go back to reference Grund JM, et al. Association between male circumcision and women’s biomedical health outcomes: a systematic review. Lancet Glob Health. 2017;5:e1113–22.PubMedPubMedCentralCrossRef Grund JM, et al. Association between male circumcision and women’s biomedical health outcomes: a systematic review. Lancet Glob Health. 2017;5:e1113–22.PubMedPubMedCentralCrossRef
16.
go back to reference Pintye J, Baeten JM. Benefits of male circumcision for MSM: evidence for action. Lancet Glob Health. 2019;7:e388–9.PubMedCrossRef Pintye J, Baeten JM. Benefits of male circumcision for MSM: evidence for action. Lancet Glob Health. 2019;7:e388–9.PubMedCrossRef
21.
go back to reference Cuadros DF, Branscum AJ, Miller FD, Awad SF, Abu-Raddad LJ. Are geographical ‘cold spots’ of male circumcision driving differential HIV dynamics in Tanzania? Front Public Health. 2015;3:218.PubMedPubMedCentralCrossRef Cuadros DF, Branscum AJ, Miller FD, Awad SF, Abu-Raddad LJ. Are geographical ‘cold spots’ of male circumcision driving differential HIV dynamics in Tanzania? Front Public Health. 2015;3:218.PubMedPubMedCentralCrossRef
22.
go back to reference Akullian A, Onyango M, Klein D, Odhiambo J, Bershteyn A. Geographic coverage of male circumcision in western Kenya. Medicine (Baltimore). 2017;96. Akullian A, Onyango M, Klein D, Odhiambo J, Bershteyn A. Geographic coverage of male circumcision in western Kenya. Medicine (Baltimore). 2017;96.
23.
go back to reference Moses S, et al. Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int J Epidemiol. 1990;19:693–7.PubMedCrossRef Moses S, et al. Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int J Epidemiol. 1990;19:693–7.PubMedCrossRef
24.
go back to reference Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS Lond. Engl. 2000;14:2361–70.CrossRef Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS Lond. Engl. 2000;14:2361–70.CrossRef
25.
go back to reference Morris BJ, et al. Estimation of country-specific and global prevalence of male circumcision. Popul Health Metrics. 2016;14:4.CrossRef Morris BJ, et al. Estimation of country-specific and global prevalence of male circumcision. Popul Health Metrics. 2016;14:4.CrossRef
26.
go back to reference Drain PK, Halperin DT, Hughes JP, Klausner JD, Bailey RC. Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis. 2006;6:172.PubMedPubMedCentralCrossRef Drain PK, Halperin DT, Hughes JP, Klausner JD, Bailey RC. Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis. 2006;6:172.PubMedPubMedCentralCrossRef
27.
go back to reference Wilcken A, Keil T, Dick B. Traditional male circumcision in eastern and southern Africa: a systematic review of prevalence and complications. Bull World Health Organ. 2010;88:907–14.PubMedPubMedCentralCrossRef Wilcken A, Keil T, Dick B. Traditional male circumcision in eastern and southern Africa: a systematic review of prevalence and complications. Bull World Health Organ. 2010;88:907–14.PubMedPubMedCentralCrossRef
29.
go back to reference Shaffer DN, et al. The protective effect of circumcision on HIV incidence in rural low-risk men circumcised predominantly by traditional circumcisers in Kenya: two-year follow-up of the Kericho HIV Cohort Study. J Acquir Immune Defic Syndr. 2007;1999(45):371–9.CrossRef Shaffer DN, et al. The protective effect of circumcision on HIV incidence in rural low-risk men circumcised predominantly by traditional circumcisers in Kenya: two-year follow-up of the Kericho HIV Cohort Study. J Acquir Immune Defic Syndr. 2007;1999(45):371–9.CrossRef
30.
go back to reference Bailey RC, Egesah O, Rosenberg S. Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull World Health Organ. 2008;86:669–77.PubMedPubMedCentralCrossRef Bailey RC, Egesah O, Rosenberg S. Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull World Health Organ. 2008;86:669–77.PubMedPubMedCentralCrossRef
32.
go back to reference Anderson S-J, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet. 2014;384:249–56.PubMedCrossRef Anderson S-J, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet. 2014;384:249–56.PubMedCrossRef
33.
go back to reference Kripke K, et al. Voluntary medical male circumcision for HIV prevention in Malawi: modeling the impact and cost of focusing the program by client age and geography. PLoS One. 2016;11:e0156521.PubMedPubMedCentralCrossRef Kripke K, et al. Voluntary medical male circumcision for HIV prevention in Malawi: modeling the impact and cost of focusing the program by client age and geography. PLoS One. 2016;11:e0156521.PubMedPubMedCentralCrossRef
34.
go back to reference Kripke K, et al. Cost and impact of voluntary medical male circumcision in South Africa: focusing the program on specific age groups and provinces. PLoS One. 2016;11:e0157071.PubMedPubMedCentralCrossRef Kripke K, et al. Cost and impact of voluntary medical male circumcision in South Africa: focusing the program on specific age groups and provinces. PLoS One. 2016;11:e0157071.PubMedPubMedCentralCrossRef
35.
go back to reference Kripke K, et al. The economic and epidemiological impact of focusing voluntary medical male circumcision for HIV prevention on specific age groups and regions in Tanzania. PLoS One. 2016;11:e0153363.PubMedPubMedCentralCrossRef Kripke K, et al. The economic and epidemiological impact of focusing voluntary medical male circumcision for HIV prevention on specific age groups and regions in Tanzania. PLoS One. 2016;11:e0153363.PubMedPubMedCentralCrossRef
37.
go back to reference Ledikwe JH, et al. Scaling-up voluntary medical male circumcision – what have we learned? HIVAIDS Auckl NZ. 2014;6:139–46. Ledikwe JH, et al. Scaling-up voluntary medical male circumcision – what have we learned? HIVAIDS Auckl NZ. 2014;6:139–46.
41.
go back to reference Lim SS, Stein DB, Charrow A, Murray CJ. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet. 2008;372:2031–46.PubMedCrossRef Lim SS, Stein DB, Charrow A, Murray CJ. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet. 2008;372:2031–46.PubMedCrossRef
43.
go back to reference Reiner RC, et al. Variation in childhood diarrheal morbidity and mortality in Africa, 2000–2015. N Engl J Med. 2018;379:1128–38.PubMedCrossRef Reiner RC, et al. Variation in childhood diarrheal morbidity and mortality in Africa, 2000–2015. N Engl J Med. 2018;379:1128–38.PubMedCrossRef
45.
go back to reference Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Ser B Stat Methodol. 2009;71:319–92.CrossRef Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Ser B Stat Methodol. 2009;71:319–92.CrossRef
49.
go back to reference McGillen JB, Anderson S-J, Dybul MR, Hallett TB. Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study. Lancet HIV. 2016;3:e441–8.PubMedCrossRef McGillen JB, Anderson S-J, Dybul MR, Hallett TB. Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study. Lancet HIV. 2016;3:e441–8.PubMedCrossRef
50.
go back to reference Mahler H, et al. Covering the last kilometer: using GIS to scale-up voluntary medical male circumcision services in Iringa and Njombe Regions, Tanzania. Glob Health Sci Pract. 2015;3:503–15.PubMedPubMedCentralCrossRef Mahler H, et al. Covering the last kilometer: using GIS to scale-up voluntary medical male circumcision services in Iringa and Njombe Regions, Tanzania. Glob Health Sci Pract. 2015;3:503–15.PubMedPubMedCentralCrossRef
52.
go back to reference Herman-Roloff A, Otieno N, Agot K, Ndinya-Achola J, Bailey RC. Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program. PLoS One. 2011;6:e19814.PubMedPubMedCentralCrossRef Herman-Roloff A, Otieno N, Agot K, Ndinya-Achola J, Bailey RC. Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program. PLoS One. 2011;6:e19814.PubMedPubMedCentralCrossRef
53.
go back to reference Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 2007;11:341–55.PubMedCrossRef Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 2007;11:341–55.PubMedCrossRef
54.
go back to reference Kibira SPS, Sandøy IF, Daniel M, Atuyambe LM, Makumbi FE. A comparison of sexual risk behaviours and HIV seroprevalence among circumcised and uncircumcised men before and after implementation of the safe male circumcision programme in Uganda. BMC Public Health. 2016;16:7.PubMedPubMedCentralCrossRef Kibira SPS, Sandøy IF, Daniel M, Atuyambe LM, Makumbi FE. A comparison of sexual risk behaviours and HIV seroprevalence among circumcised and uncircumcised men before and after implementation of the safe male circumcision programme in Uganda. BMC Public Health. 2016;16:7.PubMedPubMedCentralCrossRef
55.
go back to reference Shi C-F, Li M, Dushoff J. Evidence that promotion of male circumcision did not lead to sexual risk compensation in prioritized sub-Saharan countries. PLoS One. 2017;12. Shi C-F, Li M, Dushoff J. Evidence that promotion of male circumcision did not lead to sexual risk compensation in prioritized sub-Saharan countries. PLoS One. 2017;12.
56.
go back to reference Borgdorff MW, et al. HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision: a population-based cohort analysis. Lancet HIV. 2018;5:e241–9.PubMedCrossRef Borgdorff MW, et al. HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision: a population-based cohort analysis. Lancet HIV. 2018;5:e241–9.PubMedCrossRef
57.
go back to reference Thomas AG, et al. Voluntary medical male circumcision: a cross-sectional study comparing circumcision self-report and physical examination findings in Lesotho. PLoS One. 2011;6:e27561.PubMedPubMedCentralCrossRef Thomas AG, et al. Voluntary medical male circumcision: a cross-sectional study comparing circumcision self-report and physical examination findings in Lesotho. PLoS One. 2011;6:e27561.PubMedPubMedCentralCrossRef
58.
go back to reference Maffioli EM. Is traditional male circumcision effective as an HIV prevention strategy? Evidence from Lesotho. PLoS ONE. 2017;12(5). Maffioli EM. Is traditional male circumcision effective as an HIV prevention strategy? Evidence from Lesotho. PLoS ONE. 2017;12(5).
60.
go back to reference Gething P, Tatem A, Bird T, Burgert-Brucker CR. Creating spatial interpolation surfaces with DHS data; 2015. Gething P, Tatem A, Bird T, Burgert-Brucker CR. Creating spatial interpolation surfaces with DHS data; 2015.
61.
go back to reference Stevens FR, Gaughan AE, Linard C, Tatem AJ. Disaggregating census data for population mapping using random forests with remotely-sensed and ancillary data. PLoS One. 2015;10:e0107042.PubMedPubMedCentralCrossRef Stevens FR, Gaughan AE, Linard C, Tatem AJ. Disaggregating census data for population mapping using random forests with remotely-sensed and ancillary data. PLoS One. 2015;10:e0107042.PubMedPubMedCentralCrossRef
Metadata
Title
Mapping male circumcision for HIV prevention efforts in sub-Saharan Africa
Authors
Michael A. Cork
Kate F. Wilson
Samantha Perkins
Michael L. Collison
Aniruddha Deshpande
Jeffrey W. Eaton
Lucas Earl
Emily Haeuser
Jessica E. Justman
Damaris K. Kinyoki
Benjamin K. Mayala
Jonathan F. Mosser
Christopher J. L. Murray
John N. Nkengasong
Peter Piot
Benn Sartorius
Lauren E. Schaeffer
Audrey L. Serfes
Amber Sligar
Krista M. Steuben
Frank C. Tanser
John D. VanderHeide
Mingyou Yang
Njeri Wabiri
Simon I. Hay
Laura Dwyer-Lindgren
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2020
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-020-01635-5

Other articles of this Issue 1/2020

BMC Medicine 1/2020 Go to the issue